Krebs von den Lungen 6 (KL-6) as a marker for disease severity and persistent radiological abnormalities following COVID-19 infection at 12 weeks

• David T. Arnold,

  Roles Data curation, Project administration, Writing – review & editing

  Affiliation Academic Respiratory Unit, North Bristol NHS Trust, Bristol, United Kingdom

  https://orcid.org/0000-0003-3158-7740

  ⨯
• Charmaine Donald,

  Roles Investigation, Writing – review & editing

  Affiliation Department of Immunology, North Bristol NHS Trust, Bristol, United Kingdom

  ⨯
• Max Lyon,

  Roles Formal analysis, Writing – original draft, Writing – review & editing

  Affiliation Bristol Interstitial Lung Disease Service, North Bristol NHS Trust, Bristol, United Kingdom

  ⨯
• Fergus W. Hamilton,

  Roles Data curation, Writing – review & editing

  Affiliation Academic Respiratory Unit, North Bristol NHS Trust, Bristol, United Kingdom

  ⨯
• Anna J. Morley,

  Roles Data curation, Project administration, Writing – review & editing

  Affiliation Academic Respiratory Unit, North Bristol NHS Trust, Bristol, United Kingdom

  ⨯
• Marie Attwood,

  Roles Formal analysis, Writing – review & editing

  Affiliation Bristol Centre for Antimicrobial Research (BCARE), North Bristol NHS Trust, Bristol, United Kingdom

  ⨯
• Alexandra Dipper,

  Roles Investigation, Writing – review & editing

  Affiliation Academic Respiratory Unit, North Bristol NHS Trust, Bristol, United Kingdom

  ⨯
• Shaney L. Barratt

  Roles Conceptualization, Writing – original draft, Writing – review & editing

  * E-mail: Shaney.Barratt@nbt.nhs.uk

  Affiliations Academic Respiratory Unit, North Bristol NHS Trust, Bristol, United Kingdom, Bristol Interstitial Lung Disease Service, North Bristol NHS Trust, Bristol, United Kingdom

  https://orcid.org/0000-0003-3067-7349

  ⨯